Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 495.24 million compared to CNY 341.1 million a year ago. Revenue was CNY 495.24 million compared to CNY 341.1 million a year ago.

Net income was CNY 128.9 million compared to CNY 85.13 million a year ago. Basic earnings per share from continuing operations was CNY 1.15 compared to CNY 1.0143 a year ago. Diluted earnings per share from continuing operations was CNY 1.15 compared to CNY 1.0143 a year ago.